Protocol · Blood & Hematology
Aplastic Anemia Supportive Care Protocol
Vitamin D and Multi-Vitamin/Mineral are the core of this stack, with 5 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Aplastic Anemia Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
7 supplements · none graded yet
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Vitamin D | Amount listed: 2,000–4,000 IU daily (monitor levels; target 40–60 ng/mL) | Supports immune function and bone health; important during immunosuppressive treatment | Not graded yet | |
| Multi-Vitamin/Mineral | Amount listed: Standard multivitamin daily (avoid high-dose iron unless deficient) | Supports overall nutrition; ensure adequate micronutrients for any residual blood cell production | Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Folate | Amount listed: 400–800 mcg daily | Essential for DNA synthesis and any residual red blood cell production; support during treatment | Not graded yet | |
| Vitamin B12 | Amount listed: 500–1,000 mcg daily | Supports blood cell production; ensure adequate levels during recovery | Not graded yet | |
| Omega-3 Fatty Acids | Amount listed: 1–2 g EPA+DHA daily | Anti-inflammatory; may support immune modulation during treatment | Not graded yet | |
| Vitamin C | Amount listed: 500–1,000 mg daily (moderate doses) | Supports immune function; enhances iron absorption if iron supplementation is needed | Not graded yet | |
| Probiotics | Amount listed: 10–20 billion CFU daily (discuss with hematologist - avoid if severely neutropenic) | Support gut health and immune function during immunosuppressive treatment | Not graded yet | |
How this protocol works
In plain language
Aplastic anemia is a rare but serious condition where the bone marrow fails to produce enough blood cells - red cells, white cells, and platelets. This leads to anemia (fatigue, shortness of breath), increased infections (from low white cells), and bleeding problems (from low platelets). Causes include autoimmune attack on bone marrow, toxins, certain medications, viral infections, or inherited conditions, though many cases are idiopathic (unknown cause).
CRITICAL: Aplastic anemia is a life-threatening condition requiring immediate hematology care. Treatment depends on severity and may include immunosuppressive therapy (ATG + cyclosporine), bone marrow transplant (especially for younger patients with matched donors), or supportive care with transfusions. NO SUPPLEMENT CAN TREAT APLASTIC ANEMIA. These supplements provide general nutritional support during treatment but don't address the underlying bone marrow failure. Always coordinate any supplements with your hematologist.
Vitamin D* supports immune function and bone health. During immunosuppressive treatment, maintaining adequate vitamin D levels is important for overall health.
Multi-Vitamin/Mineral* provides general nutritional support to ensure adequate micronutrients. Avoid high-dose iron supplements unless specifically deficient and prescribed - excess iron can be harmful.
Folate* is essential for DNA synthesis and blood cell production. Ensuring adequate folate supports any residual bone marrow function.
Vitamin B12* works with folate to support blood cell production. Deficiency can worsen anemia.
Omega-3 Fatty Acids* have anti-inflammatory effects and may provide general immune support.
Vitamin C* supports immune function and enhances iron absorption if iron supplementation is needed.
Probiotics* may support gut health during treatment, but should be used cautiously and only with physician approval in immunocompromised patients.
Expected timeline: Aplastic anemia treatment takes months to years. Immunosuppressive therapy shows response in 60-70% of patients over 3-6 months. Bone marrow transplant is potentially curative. Supplements provide ongoing supportive care but don't accelerate bone marrow recovery.